Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

5 days ago 7
ARTICLE AD BOX
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.
Read Entire Article
  1. Homepage
  2. Finance
  3. Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Related

Love your stock-index fund? It might be time to spice up your investment strategy.

Love your stock-index fund? It might be time to spice up you...

15 minutes ago 0
Americans are nerve-wracked about the economy as Black Friday and the holiday shopping season kick off. Consumer confidence slumps again.

Americans are nerve-wracked about the economy as Black Frida...

19 minutes ago 0
Hollister sales are booming, and that’s making the Abercrombie brand look bad

Hollister sales are booming, and that’s making the Abercromb...

24 minutes ago 0

Trending

1. bank of america
2. delta airlines
3. andy cohen
4. aida victoria merlano
5. amd stock
6. horoscope
7. marlo thomas
8. stuffing
9. orcl stock
10. goog stock

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

8 months ago 384
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

9 months ago 343
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

9 months ago 336
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

8 months ago 315
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

9 months ago 306
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved